115 / 144
115
9. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients
with diabetic retinopathy: Visual outcome, progression of diabetic retinopathy,
and incidence of diabetic macular oedema. Graefe’s Arch Clin Exp Ophthalmol.
2002;240(9):735-738.
10. Romero-Aroca P, Fernández-Ballart J, Almena-Garcia M, Méndez-Marín I, Salvat-
-Serra M, Buil-Calvo JA. Nonproliferative diabetic retinopathy and macular edema
progression after phacoemulsi%cation: Prospective study. J Cataract Refract Surg.
2006;32(9):1438-1444.
11. Benson WE, Brown GC, Tasman W, McNamara JA, Vander JF. Extracapsular cataract
extraction with placement of a posterior chamber lens in patients with diabetic reti-
nopathy. Ophthalmology. 1993;100(5):730-8.
12. Samanta A, Kumar P, Machhua S, Rao GN, Pal A. Incidence of cystoid macular oede-
ma in diabetic patients after phacoemulsi%cation and free radical link to its pathoge-
nesis. Br J Ophthalmol. 2014;98(9):1266-72.
13. Diabetic Retinopathy Clinical Research Network Authors/Writing Committee TDR-
CR, Baker CW, Almukhtar T, et al. Macular edema after cataract surgery in eyes
without preoperative central-involved diabetic macular edema. JAMA Ophthalmol.
2013;131(7):870-9.
14. Kim SJ, Equi R, Bressler NM. Analysis of Macular Edema after Cataract Surgery in
Patients with Diabetes Using Optical Coherence Tomography. Ophthalmology.
2007;114(5):881-889.
15. Nelson ML, Martidis A. Managing cystoid macular edema after cataract surgery. Curr
Opin Ophthalmol. 2003;14(1):39-43.
16. Munk MR, Jampol LM, Simader C, et al. Differentiation of Diabetic Macular Edema
From Pseudophakic Cystoid Macular Edema by Spectral-Domain Optical Coherence
Tomography. Investig Opthalmology Vis Sci. 2015;56(11):6724.
17. Callanan D, Williams P. Topical nepafenac in the treatment of diabetic macular ede-
ma. Clin Ophthalmol. 2008;2(4):689-692.
18. Singh R, Alpern L, Jaffe GJ, et al. Evaluation of nepafenac in prevention of macular
edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthal-
mol. 2012;6:1259-1269.
19. Singh R, Staurenghi G, Pollack A, et al. Ef%cacy of nepafenac ophthalmic suspen-
sion 0.1% in improving clinical outcomes following cataract surgery in patients with
diabetes: an analysis of two randomized studies. Clin Ophthalmol. 2017;Volume
11:1021-1029.
20. Chae JB, Joe SG, Yang SJ, et al. Effect of combined cataract surgery and ranibizumab
injection in postoperative macular edema in nonproliferative diabetic retinopathy.
Retina. 2014;34(1):149-56.
21. Callanan D, Williams P. Topical nepafenac in the treatment of diabetic macular ede-
ma. Clin Ophthalmol. 2008;2(4):689-92.
22. Akinci A, Muftuoglu O, Altinsoy A, Ozkilic E. Phacoemulsi%cation with intravitreal
bevacizumab and triamcinolone acetonide injection in diabetic patients with clini-
cally signi%cant macular edema and cataract. Retina. 2011;31(4):755-758.